PSP001 - A First-in-disease human PEGIFN-λ Chimera

Feb 3rd 2021. FDA issued letter "Safe-to-proceed";
Date:2019-08-05 18:47:43 | Visits:


 
 Prev:
 Next:Jan 7th, 2021 FDA IND Submission;